| Literature DB >> 33486728 |
Julyanne Brassard1, David Marsolais1, Marie-Renee Blanchet2.
Abstract
Eosinophilia is a hallmark of allergic airway inflammation, and eosinophils represent an integral effector leukocyte through their release of various granule-stored cytokines and proteins. Numerous mouse models have been developed to mimic clinical disease and they have been instrumental in furthering our understanding of the role of eosinophils in disease. Most of these models consist of intranasal (i.n.) administration of antigenic proteases including papain and house dust mite (HDM) or the neo-antigen ovalbumin, with a resulting Th2-biased immune response and airway eosinophilia. These models have been particularly informative when combined with the numerous transgenic mice available that modulate eosinophil frequency or the mechanisms involved in their migration. Here, we describe the current models of allergic airway inflammation and outline some of the transgenic mice available to study eosinophil disease.Entities:
Keywords: Asthma; Eosinophil; Inflammation; Mouse
Year: 2021 PMID: 33486728 DOI: 10.1007/978-1-0716-1095-4_6
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745